Please use this identifier to cite or link to this item: https://dora.health.qld.gov.au/qldresearchjspui/handle/1/6179
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCraig Wallington-Gatesen
dc.date.accessioned2024-08-08T03:16:49Z-
dc.date.available2024-08-08T03:16:49Z-
dc.date.issued2019-
dc.identifier.citationHemaSphere, 2019en
dc.identifier.urihttps://dora.health.qld.gov.au/qldresearchjspui/handle/1/6179-
dc.language.isoenen
dc.titlePS1383 A SEQUENTIAL COHORT STUDY COMPARING KAPPAMAB ALONE TO KAPPAMAB, LENALIDOMIDE AND LOW DOSE DEXAMETHASONE IN KAPPA-RESTRICTED RELAPSED REFRACTORY (RR) MULTIPLE MYELOMA (AMARC 01–16)en
dc.typeArticleen
dc.identifier.doi10.1097/01.hs9.0000563808.41508.98-
dc.rights.holderCraig Wallington-Gatesen
dc.identifier.journaltitleHemaSphere-
dc.identifier.external96782336-
item.cerifentitytypePublications-
item.fulltextNo Fulltext-
item.languageiso639-1en-
item.openairetypeArticle-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
Appears in Sites:Queensland Health Publications
Sunshine Coast HHS Publications
Show simple item record

Page view(s)

318
checked on May 21, 2026

Google ScholarTM

Check

Altmetric


Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.